These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6768115)

  • 1. The direct inhibition of prostaglandin synthetase of human breast cancer tumor tissue by tamoxifen.
    Ritchie GA
    Recent Results Cancer Res; 1980; 71():96-101. PubMed ID: 6768115
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of prostaglandin E produced by osteoblasts in osteolysis due to bone metastasis.
    Ohshiba T; Miyaura C; Ito A
    Biochem Biophys Res Commun; 2003 Jan; 300(4):957-64. PubMed ID: 12559967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of effects of aspirin and indomethacin on human platelet prostaglandin synthetase.
    Crook D; Collins AJ
    Ann Rheum Dis; 1977 Oct; 36(5):459-63. PubMed ID: 411427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bone targeting agents: bisphosphonates].
    Debiais F
    Bull Cancer; 2013 Nov; 100(11):1199-206. PubMed ID: 24158668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased cyclooxygenase-2 (cox-2) expression and activity in a murine model of metastatic breast cancer.
    Kundu N; Yang Q; Dorsey R; Fulton AM
    Int J Cancer; 2001 Sep; 93(5):681-6. PubMed ID: 11477578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibition by aspirin and indomethacin of osteolytic tumor deposits and hypercalcaemia in rats with Walker tumour, and its possible application to human breast cancer.
    Powles TJ; Clark SA; Easty DM; Easty GC; Neville AM
    Br J Cancer; 1973 Oct; 28(4):316-21. PubMed ID: 4759939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast-cancer osteolysis, bone metastases, and anti-osteolytic effect of aspirin.
    Powles TJ; Dowsett M; Easty GC; Easty DM; Neville AM
    Lancet; 1976 Mar; 1(7960):608-10. PubMed ID: 55892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Synthetic salmon calcitonin in the therapeutic management of osteolytic metastases of breast carcinoma].
    Simone C; Racanelli A
    Clin Ter; 1981 Aug; 98(3):247-67. PubMed ID: 7285537
    [No Abstract]   [Full Text] [Related]  

  • 9. Failure of indomethacin to reduce hypercalcemia in patients with breast cancer.
    Coombes RC; Neville AM; Bondy PK; Powles TJ
    Prostaglandins; 1976 Dec; 12(6):1027-35. PubMed ID: 1005735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro osteolysis by human breast tumours.
    Easty GC; Dowsett M; Powles TJ; Easty DM; Gazet JC; Neville AM
    Proc R Soc Med; 1977 Mar; 70(3):191-5. PubMed ID: 193116
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence that the bone resorption-stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E 2 . A new model for the hypercalcemia of cancer.
    Tashjian AH; Voelkel EF; Levine L; Goldhaber P
    J Exp Med; 1972 Dec; 136(6):1329-43. PubMed ID: 4345106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agents affecting osteolysis in patients with breast cancer.
    Coombes RC; Neville AM; Gazet JC; Ford HT; Nash AG; Baker JW; Powles JT
    Cancer Chemother Pharmacol; 1979; 3(1):41-4. PubMed ID: 161206
    [No Abstract]   [Full Text] [Related]  

  • 13. Prostaglandins and cancer.
    Smith BJ; Wills MR; Savory J
    Ann Clin Lab Sci; 1983; 13(5):359-65. PubMed ID: 6357045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of prostaglandin synthesis inhibitors and diphosphonates on tumour-mediated osteolysis.
    Galasko CS; Samuel AW; Rushton S; Lacey E
    Br J Surg; 1980 Jul; 67(7):493-6. PubMed ID: 7417751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone resorption and humoral hypercalcemia of malignancy: stimulation of bone resorption in vitro by tumor extracts is inhibited by prostaglandin synthesis inhibitors.
    Minkin C; Fredericks RS; Pokress S; Rude RK; Sharp CF; Tong M; Singer FR
    J Clin Endocrinol Metab; 1981 Nov; 53(5):941-7. PubMed ID: 6793615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone metastases studied in experimental animals.
    Galasko CS
    Clin Orthop Relat Res; 1981; (155):269-85. PubMed ID: 7014059
    [No Abstract]   [Full Text] [Related]  

  • 17. Human breast tumour-induced osteolysis and prostaglandins.
    Dowsett M; Easty GC; Powles TJ; Easty DM; Neville AM
    Prostaglandins; 1976 Mar; 11(3):447-60. PubMed ID: 948618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the interaction of specific prostaglandin H synthase-2 inhibitors with prostaglandin H synthase-1.
    Burde T; Rimon G
    Eur J Pharmacol; 2002 Oct; 453(2-3):167-73. PubMed ID: 12398900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of tumor-induced osteolysis by APD.
    Burckhardt P; Thiébaud D; Perey L; von Fliedner V
    Recent Results Cancer Res; 1989; 116():54-66. PubMed ID: 2762665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model.
    Canon J; Bryant R; Roudier M; Branstetter DG; Dougall WC
    Breast Cancer Res Treat; 2012 Oct; 135(3):771-80. PubMed ID: 22926264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.